A Case Study and Review of the Literature on <scp>IgA</scp> Nephropathy in Crohn's Disease

IgA nephropathy (IgAN) is the most frequently reported glomerular disease associated with inflammatory bowel disease (IBD), particularly Crohn's disease (CD), although pediatric cases remain rare. We report IgAN in a 16-year-old male with CD following intestinal surgery and during long-term infliximab therapy, with renal impairment occurring independently of bowel disease activity. The patient presented with recurrent macroscopic hematuria, proteinuria, and acute kidney injury despite sustained intestinal remission. Renal biopsy confirmed IgAN (MEST-C: M0, E0, S1, T0, C1). Treatment with renin-angiotensin system (RAS) blockade and corticosteroids resulted in complete renal remission. Infliximab was discontinued, and a subsequent intestinal flare was successfully treated with ustekinumab. This case highlights the importance of vigilant renal monitoring in pediatric CD, particularly in patients with prior intestinal surgery or long-term biologic therapy.

Authors

Institutions

Publication Details

Journal
Clinical Case Reports
Published
2026-04-01
DOI
https://doi.org/10.1002/ccr3.72418
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease

Giovanni Vazzana, Alessia Romano, Roberto Chimenz, Alberto Spada et al.
Clinical Case Reports
Renal Diseases and Glomerulopathies
article

A Case Study and Review of the Literature on IgA Nephropathy in Crohn's Disease

Giovanni Vazzana, Alessia Romano, Roberto Chimenz, Alberto Spada, Chiara Casuscelli, Claudio Romano, Domenico Santoro
article en

Abstract

IgA nephropathy (IgAN) is the most frequently reported glomerular disease associated with inflammatory bowel disease (IBD), particularly Crohn's disease (CD), although pediatric cases remain rare. We report IgAN in a 16-year-old male with CD following intestinal surgery and during long-term infliximab therapy, with renal impairment occurring independently of bowel disease activity. The patient presented with recurrent macroscopic hematuria, proteinuria, and acute kidney injury despite sustained intestinal remission. Renal biopsy confirmed IgAN (MEST-C: M0, E0, S1, T0, C1). Treatment with renin-angiotensin system (RAS) blockade and corticosteroids resulted in complete renal remission. Infliximab was discontinued, and a subsequent intestinal flare was successfully treated with ustekinumab. This case highlights the importance of vigilant renal monitoring in pediatric CD, particularly in patients with prior intestinal surgery or long-term biologic therapy.

Clinical Case ReportsVol. 14(4)
University of Messina (IT), University of Rome Tor Vergata (IT), Martin University (US), Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT)
Good health and well-being
Openalex Percentile: Top 33%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.